Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.850
+0.100 (5.71%)
At close: Jan 2, 2026, 4:00 PM EST
1.820
-0.030 (-1.62%)
After-hours: Jan 2, 2026, 4:00 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $174.96 million as of January 2, 2026. Its market cap has increased by 5.45% in one year.
Market Cap
174.96M
Enterprise Value
136.20M
1-Year Change
5.45%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $174.96M, an increase of 39.73%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 174.96M | 0.91% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |